Patents by Inventor Claudio A. Cuello

Claudio A. Cuello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies against prostate specific membrane antigen
    Patent number: 8629247
    Abstract: Antibodies (Ab) and antigen binding fragments capable of binding to prostate specific membrane antigen and which may be used for diagnostic and therapeutic purposes are provided herein. Formulation anti-PSMA antibodies which are stable under extreme storage condition are also provided.
    Type: Grant
    Filed: April 14, 2010
    Date of Patent: January 14, 2014
    Assignee: Proscan RX Pharma Inc.
    Inventors: Serge Moffett, Dominic Melançon, Uri H. Saragovi, Phil Gold, Claudio A. Cuello
  • Prostate cancer diagnosis and treatment
    Patent number: 8512702
    Abstract: The present invention relates to novel antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof. The present invention also relates to novel pharmaceutical compositions for the treatment of prostate cancer. Furthermore the present invention relates to assay systems and kits for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: August 20, 2013
    Assignee: Proscan Rx Pharma Inc.
    Inventors: Claudio Cuello, Uri Saragovi, Pierre Du Ruisseau, Phil Gold, Nicole Bernard, Serge Moffett
  • ANTIBODIES AGAINST PROSTATE SPECIFIC MEMBRANE ANTIGEN
    Publication number: 20120093719
    Abstract: Antibodies (Ab) and antigen binding fragments capable of binding to prostate specific membrane antigen and which may be used for diagnostic and therapeutic purposes are provided herein. Formulation anti-PSMA antibodies which are stable under extreme storage condition are also provided.
    Type: Application
    Filed: April 14, 2010
    Publication date: April 19, 2012
    Applicant: PROSCAN RX PHARMA INC.
    Inventors: Serge Moffett, Dominic Melançon, Uri H. Saragovi, Phil Gold, Claudio A. Cuello
  • PROSTATE CANCER DIAGNOSIS AND TREATMENT
    Publication number: 20120082618
    Abstract: The present invention relates to novel antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof. The present invention also relates to novel pharmaceutical compositions for the treatment of prostate cancer. Furthermore the present invention relates to assay systems and kits for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof.
    Type: Application
    Filed: December 14, 2011
    Publication date: April 5, 2012
    Applicant: PROSCAN RX PHARMA INC.
    Inventors: CLAUDIO CUELLO, URI SARAGOVI, PIERRE DU RUISSEAU, PHIL GOLD, NICOLE BERNARD, SERGE MOFFETT
  • Prostate cancer diagnosis and treatment
    Patent number: 8101713
    Abstract: The present invention relates to novel antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof. The present invention also relates to novel pharmaceutical compositions for the treatment of prostate cancer. Furthermore the present invention relates to assay systems and kits for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: January 24, 2012
    Assignee: Proscan RX Pharma Inc.
    Inventors: Claudio Cuello, Uri Saragovi, Pierre Du Ruisseau, Phil Gold, Nicole Bernard, Serge Moffett
  • PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODIES AND ANTIGEN BINDING FRAGMENTS
    Publication number: 20110189093
    Abstract: Polypeptides, antibodies or antigen-binding fragments capable of binding to prostate specific membrane antigen (PSMA) are provided. These polypeptides, antibodies or antigen-binding fragments may be used for diagnostic and/or therapeutic purposes.
    Type: Application
    Filed: April 14, 2009
    Publication date: August 4, 2011
    Applicant: PROSCAN RX PHARMA
    Inventors: Serge Moffett, Dominic Melancon, Uri H. Saragovi, Phil Gold, Claudio A. Cuello
  • Prostate cancer diagnosis and treatment
    Patent number: 7910693
    Abstract: The present invention relates to novel mimetopes of anti-PSMA antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastatis thereof. The present invention also relates to novel pharmaceutical compositions for the treatment of prostate cancer. Furthermore the present invention relates to assay systems and kits for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof.
    Type: Grant
    Filed: April 19, 2005
    Date of Patent: March 22, 2011
    Assignee: ProScan Rx Pharma Inc.
    Inventors: Claudio Cuello, Uri Saragovi, Pierre Du Ruisseau, Phil Gold, Serge Moffett
  • PROSTATE CANCER DIAGNOSIS AND TREATMENT
    Publication number: 20110064654
    Abstract: The present invention relates to novel antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof. The present invention also relates to novel pharmaceutical compositions for the treatment of prostate cancer. Furthermore the present invention relates to assay systems and kits for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof.
    Type: Application
    Filed: September 10, 2010
    Publication date: March 17, 2011
    Applicant: Proscan Rx Pharma Inc.
    Inventors: Claudio Cuello, Uri Saragovi, Pierre Du Ruisseau, Phil Gold, Nicole Bernard, Serge Moffett
  • Prostate cancer diagnosis and treatment
    Patent number: 7811564
    Abstract: The present invention relates to novel antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof. The present invention also relates to novel pharmaceutical compositions for the treatment of prostate cancer. Furthermore the present invention relates to assay systems and kits for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof.
    Type: Grant
    Filed: January 28, 2004
    Date of Patent: October 12, 2010
    Assignee: Proscan RX Pharma
    Inventors: Claudio Cuello, Uri Saragovi, Pierre Du Ruisseau, Phil Gold, Nicole Bernard, Serge Moffet
  • PROSTATE CANCER DIAGNOSIS AND TREATMENT
    Publication number: 20090131277
    Abstract: The present invention relates to novel mimetopes of anti-PSMA antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastatis thereof. The present invention also relates to novel pharmaceutical compositions for the treatment of prostate cancer. Furthermore the present invention relates to assay systems and kits for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof.
    Type: Application
    Filed: April 19, 2005
    Publication date: May 21, 2009
    Applicant: PROSCAN RX PHARMA
    Inventors: Claudio Cuello, Uri Saragovi, Pierre Du Ruisseau, Phil Gold, Serge Moffett
  • Prostate cancer diagnosis and treatment
    Publication number: 20070036719
    Abstract: The present invention relates to novel antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof. The present invention also relates to novel pharmaceutical compositions for the treatment of prostate cancer. Furthermore the present invention relates to assay systems and kits for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis thereof.
    Type: Application
    Filed: January 28, 2004
    Publication date: February 15, 2007
    Inventors: Claudio Cuello, Uri Saragovi, Pierre Du Ruisseau, Phil Gold, Nicole Bernard, Serge Moffet
  • Nerve growth factor structural analogs and their uses
    Patent number: 6017878
    Abstract: Cyclic compounds with a 3-dimensional structure that bind at least one neurotrophin receptor (NTR) under physiologic conditions in vitro or in vivo are new. Binding to NTR at least partially mimics or inhibits NT biological activity.
    Type: Grant
    Filed: August 7, 1996
    Date of Patent: January 25, 2000
    Assignee: McGill University
    Inventors: Uri H. Saragovi, Lynne Lesauteur, Claudio A. Cuello